
Molecular Templates (MTEM) Stock Forecast & Price Target
Molecular Templates (MTEM) Analyst Ratings
Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 29%
Hold 14%
Sell 14%
Strong Sell 0%
Molecular Templates (MTEM) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 29% recommend Buy, 14% suggest Holding, 14% advise Selling, and 0% predict a Strong Sell.
This aggregate rating is based on analysts' research of Molecular Templates and is not a guaranteed prediction by Public.com or investment advice.
This aggregate rating is based on analysts' research of Molecular Templates and is not a guaranteed prediction by Public.com or investment advice.
Molecular Templates (MTEM) Analyst Forecast & Price Prediction
Get the latest Molecular Templates (MTEM) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis
Start investing in Molecular Templates (MTEM)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Molecular Templates (MTEM) Forecast
Analysts have given Molecular Templates (MTEM) a Buy based on their latest research and market trends.
According to 7 analysts, Molecular Templates (MTEM) has a Buy consensus rating as of Sep 19, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.
Wall Street analysts have set a price target of $12.50, reflecting a 0.00% increase from the current stock price.
Financial analysts have set a price target of $12.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.